Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal
暂无分享,去创建一个
W. Ageno | F. Dentali | D. Imberti | E. Croci | E. Tamburini Permunian | Eleonora Tamburini Permunian
[1] W. Ageno,et al. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding , 2013, Journal of Thrombosis and Thrombolysis.
[2] J. Menzin,et al. Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records , 2012, Journal of thrombosis and haemostasis : JTH.
[3] Mark Crowther,et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[4] B. Erstad,et al. Dosing of 3-Factor Prothrombin Complex Concentrate for International Normalized Ratio Reversal , 2012, The Annals of pharmacotherapy.
[5] W. Ageno,et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists , 2011, Thrombosis and Haemostasis.
[6] J. Douketis,et al. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment , 2009, American journal of hematology.
[7] M. Crowther,et al. Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose , 2009, Transfusion.
[8] C. Samama. Prothrombin complex concentrates: a brief review , 2008, European journal of anaesthesiology.
[9] W. Ageno,et al. Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage , 2007, Pathophysiology of Haemostasis and Thrombosis.
[10] W. Ageno,et al. Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms , 2006, Journal of thrombosis and haemostasis : JTH.
[11] D. Garcia,et al. A survey of oral vitamin K use by anticoagulation clinics. , 2002, Archives of internal medicine.
[12] Vittorio Pengo,et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.